21 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33141329 | HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer. | 2021 Jan | 2 |
2 | 32053149 | HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer. | 2020 Apr 1 | 1 |
3 | 32866512 | Germline HSD3B1 Genetics and Prostate Cancer Outcomes. | 2020 Nov | 3 |
4 | 29049452 | HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer. | 2018 Apr 1 | 1 |
5 | 29049492 | Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer. | 2018 Apr 1 | 1 |
6 | 29674118 | Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer. | 2018 Aug | 1 |
7 | 29939161 | HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. | 2018 Aug 1 | 3 |
8 | 27139182 | Human 3β-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations. | 2016 Jul | 2 |
9 | 27561382 | Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone. | 2016 Aug 26 | 3 |
10 | 27575027 | HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. | 2016 Oct | 2 |
11 | 26030522 | Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer. | 2015 Jul 16 | 1 |
12 | 22753664 | Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer. | 2012 Jul 1 | 2 |
13 | 17826523 | Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. | 2007 Aug | 4 |
14 | 14672942 | Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. | 2004 Mar 12 | 1 |
15 | 15383625 | Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. | 2004 Dec | 1 |
16 | 15666817 | Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. | 2004 Nov | 4 |
17 | 14643063 | Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. | 2003 Dec | 4 |
18 | 10487690 | Metabolism of dihydrotestosterone in human liver: importance of 3alpha- and 3beta-hydroxysteroid dehydrogenase. | 1999 Sep | 8 |
19 | 8547174 | Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family. | 1995 Dec | 1 |
20 | 1944309 | Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. | 1991 Aug | 1 |
21 | 3165109 | delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness. | 1988 Aug | 1 |